All Insights
Showing 1 - 4 of 4
Life sciences and healthcare
Draghi report on EU competitiveness offers new recommendations for pharma and biotech
The former European central banker's report delivers strategic insights for pharma companies doing business in the EU
Life sciences and healthcare
EU competitiveness report pushes for greener and digitalised medical and IVD
The Draghi report warns of the major impact on medical device firms from digitalisation and heavy regulation
Financial services
ESMA sets stricter guidelines for ESG and sustainability-related fund names
New rules, aimed at reducing greenwashing, require stricter criteria for funds using ESG or sustainability terms - though some uncertainties
Regulatory and compliance
PFAS and products: how to prepare for change in Europe
Businesses using PFAS in their products or supply chain need to understand how regulatory changes will affect them
